Bioequivalence and Bioavailability Forum 21:25 CEST

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

ULOQ [Study As­sess­ment]

posted by Anand - India, 2017-10-30 06:38  - Posting: # 17945
Views: 3,283

Dear All,

Request to clarify,

In our Pivotal BE Study ULOQ was observed, whether we should exclude from PK?
After Dilution also it found ULOQ.
Method should be redeveloped or revalidated?
If included,What justification we should provide to Regulatory Agency?

Thanks in advance.

Regards,
A.A


Edit: Category changed; see also this post #1. [Helmut]

Complete thread:

Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
18,783 posts in 4,003 threads, 1,258 registered users;
online 10 (0 registered, 10 guests [including 3 identified bots]).

To propose that poor design can be corrected by subtle analysis techniques
is contrary to good scientific thinking.    Stuart J. Pocock

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5 RSS Feed